Bixiye
QP50-23 Fetal Alcohol Syndrome Education Opportunity
Taariikhda wax ku ool ah ee barnaamijka: Jun 14, 2023
Natiijooyinka Raadinta
Soo bandhiga 1981 - 1990 ee natiijooyinka 4163
Bixiye
QP51-23 Commercial Pharmacy Benefit Exclusion for Aponvie™, Iheezo™, Omisirge®, and Qalsody™
Taariikhda wax ku ool ah ee barnaamijka: Jun 14, 2023
Bixiye
QP52-23 MHCP Pharmacy Benefit Exclusion for Iheezo™, Omisirge®, and Qalsody™
Taariikhda wax ku ool ah ee barnaamijka: Jun 14, 2023
Bixiye
QP53-23 Commercial Pharmacy Benefit Update: Revised Drug-Related Prior Authorization (PA) Requirement Notification, Effective August 1, 2023
Taariikhda wax ku ool ah ee barnaamijka: Jun 14, 2023
Bixiye
QP54-23 MHCP Pharmacy Benefit Update: New and Revised Drug-Related Prior Authorization (PA) Requirement Notification, Effective July 1, 2023
Taariikhda wax ku ool ah ee barnaamijka: Jun 14, 2023
Bixiye
QP55-23 Change in Processing for Replacement Claims
Taariikhda wax ku ool ah ee barnaamijka: Jun 14, 2023
Faa'iidooyinka & Caymiska
2023 Blue Cross Dental Plans Individual and Family Plan Rates
Bixiye
P46-23 Services Removed from the Commercial Prior Authorization List
Taariikhda wax ku ool ah ee barnaamijka: Jun 01, 2023
Bixiye
P23R1-23 Laboratory Services: Lab Rebundling Reimbursement Policy will not be Updated
Taariikhda wax ku ool ah ee barnaamijka: Jun 01, 2023
Faa'iidooyinka & Caymiska
2025 Individual and Family Dental Preferred Plan